Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing phase IV study of human coagulation factor VIII in patients with hemophilia A
CTR20240117Phase 4Completed
- Sponsor
- Chengdu Rongsheng Pharmaceutical
- Start
- Apr 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of antihemophilic factor human in hemophilia A, sponsored by Chengdu Rongsheng Pharmaceutical. Started Apr 2024; status: completed.
02
Drugs
antihemophilic factor human
03
Conditions
hemophilia A
Beyond the preview
Go deeper on CTR20240117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240117.